Biora Therapeutics (BIOR) Earnings Date, Estimates & Call Transcripts $0.57 +0.05 (+9.55%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 11EstimatedActual EPS (Aug. 12) -$0.35 Beat By $0.10 Consensus EPS (Aug. 12) -$0.45 Get Biora Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIOR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIOR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIOR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaNext opportunity for crypto millionsOctober isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…Go here to discover the coin that could define this historic bull run with gains kicking off this mo Biora Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.45)($0.45)($0.45) Q2 20241($0.42)($0.42)($0.42) Q3 20241($0.42)($0.42)($0.42) Q4 20241($0.43)($0.43)($0.43) FY 20244($1.72)($1.72) ($1.72)BIOR Earnings Date and InformationBiora Therapeutics last issued its quarterly earnings results on August 12th, 2024. The reported ($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.45) by $0.10. The company had revenue of $0.32 million for the quarter. Biora Therapeutics has generated ($7.12) earnings per share over the last year (($7.12) diluted earnings per share). Earnings for Biora Therapeutics are expected to grow in the coming year, from ($1.25) to ($1.15) per share. Biora Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off prior year's report dates.Read More Biora Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/11/2024(Estimated)------- 8/12/2024Q2 2024($0.45)($0.35)+$0.10($0.66)-$0.32 million5/15/2024Q1 2024($0.45)($0.61)($0.16)($1.08)-$0.54 million3/26/2024Q4 2023($0.60)($0.63)($0.03)($0.64)--11/13/2023Q3 2023($0.93)($0.75)+$0.18$3.39--8/14/2023Q2 2023($1.60)($1.47)+$0.13($1.47)--5/15/2023Q1 2023-($1.59)($1.59)($1.59)-- Get the Latest News and Ratings for BIOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/30/2023Q4 2022($0.89)($1.61)($0.72)($1.58)$0.11 million$0.01 million11/14/2022Q3 2022($37.50)($50.00)($12.50)($0.13)$0.10 million$0.08 million8/15/2022Q2 2022($81.25)($18.75)+$62.50($0.03)-$0.10 million 5/10/2022Q1 2022($75.00)($75.00)-($0.16)-$0.11 million3/28/2022Q4 2021($81.25)($131.25)($50.00)$0.14-$0.44 million3/28/2022Q4 2021($0.13)($0.21)($0.08)$0.14-$0.44 million 11/10/2021Q3 2021($293.75)($237.50)+$56.25($0.30)$11.10 million$0.18 million11/10/2021Q3 2021($0.47)($0.46)+$0.01($0.30)$11.10 million$0.18 million 8/12/2021Q2 2021($500.00)($406.25)+$93.75($0.07)$19.99 million$0.46 million8/12/2021Q2 2021($0.80)($0.65)+$0.15($0.07)$19.99 million$0.46 million 5/13/2021Q1 2021($518.75)($350.00)+$168.75($0.56)$26.24 million$24.53 million5/13/2021Q1 2021($0.83)($0.56)+$0.27($0.56)$26.24 million$24.53 million 3/18/2021Q4 2020($475.00)($956.25)($481.25)($1.53)$23.62 million$14.28 million3/17/2021Q4 2020($0.82)($1.53)($0.71)($1.53)$23.62 million$14.28 million 11/9/2020Q3 2020($387.50)($631.25)($243.75)($1.01)$25.50 million$25.94 million11/9/2020Q3 2020($0.62)($1.01)($0.39)($1.01)$25.50 million$25.94 million 8/13/2020Q2 2020($475.00)($3,818.75)($3,343.75)($6.11)$26.35 million$17.27 million8/13/2020Q2 2020($0.83)($6.11)($5.28)($6.11)$26.35 million$17.27 million Biora Therapeutics Earnings - Frequently Asked Questions When is Biora Therapeutics's earnings date? Biora Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on BIOR's earnings history. Did Biora Therapeutics beat their earnings estimates last quarter? In the previous quarter, Biora Therapeutics (NASDAQ:BIOR) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.10. Learn more on analysts' earnings estimate vs. BIOR's actual earnings. How much revenue does Biora Therapeutics generate each year? Biora Therapeutics (NASDAQ:BIOR) has a recorded annual revenue of $860,000.00. How much profit does Biora Therapeutics generate each year? Biora Therapeutics (NASDAQ:BIOR) has a recorded net income of -$124.11 million. BIOR has generated -$7.12 earnings per share over the last four quarters. What is Biora Therapeutics's EPS forecast for next year? Biora Therapeutics's earnings are expected to grow from ($1.25) per share to ($1.15) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RNLX Earnings Date MEIP Earnings Date CUE Earnings Date XGN Earnings Date ENZ Earnings Date SPRO Earnings Date BIVI Earnings Date DBVT Earnings Date IOBT Earnings Date IMRX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:BIOR) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.